Isofol Medical AB (publ)
556759-8064ActiveDeveloping next-generation folate drug to improve cancer treatment efficacy.
Oversigt
- 10–19
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2008
- Grundlagt
Beskrivelse
Isofol is a publicly listed biotechnology company focused on advancing cancer care. The organization is dedicated to developing its drug candidate, arfolitixorin, a novel folate-based therapy. Arfolitixorin is specifically designed to enhance the efficacy of standard first-line treatments for severe...
Tags
Nøgleord
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556759806401
Beslutningstagere
Ingen beslutningstagere fundet endnu
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
NUCLITHERA AS
9 medarbejdereDeveloping targeted alpha and beta emitters for metastatic cancer treatment.
Exocure Sweden AB
Exocure pioneers exosome biotechnology for advanced cancer therapeutics.
Ambusol AB (publ)
1–4 medarbejderePioneering patented therapy to eradicate residual glioblastoma cells post-surgery.
BioGaia Pharma AB
0 medarbejdereDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
Medivir Aktiebolag
10–19 medarbejdereDeveloping transformative pharmaceutical treatments for unmet cancer needs.
Udforsk mere
Spørgsmål om Isofol Medical AB (publ)
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo